These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 6222137)

  • 1. Expression of C5a-like biological activities by the fifth component of human complement (C5) upon limited digestion with noncomplement enzymes without release of polypeptide fragments.
    Wetsel RA; Kolb WP
    J Exp Med; 1983 Jun; 157(6):2029-48. PubMed ID: 6222137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement activation in cystic fibrosis respiratory fluids: in vivo and in vitro generation of C5a and chemotactic activity.
    Fick RB; Robbins RA; Squier SU; Schoderbek WE; Russ WD
    Pediatr Res; 1986 Dec; 20(12):1258-68. PubMed ID: 3540828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotactic factor for tumor cells derived from the C5a fragment of complement component C5.
    Orr W; Phan SH; Varani J; Ward PA; Kreutzer DL; Webster RO; Henson PM
    Proc Natl Acad Sci U S A; 1979 Apr; 76(4):1986-9. PubMed ID: 287038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement-independent activation of the fifth component (C5) of human complement: limited trypsin digestion resulting in the expression of biological activity.
    Wetsel RA; Kolb WP
    J Immunol; 1982 May; 128(5):2209-16. PubMed ID: 7061860
    [No Abstract]   [Full Text] [Related]  

  • 5. Digestion of the fifth component of complement by leukocyte enzymes. Sequential generation of chemotactic activities for leukocytes and for tumor cells.
    Orr FW; Varani J; Kreutzer DL; Senior RM; Ward PA
    Am J Pathol; 1979 Jan; 94(1):75-83. PubMed ID: 569981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cleavage of human C5 by trypsin: characterization of the digestion products by gel electrophoresis.
    Minta JO; Man DP
    J Immunol; 1977 Nov; 119(5):1597-1602. PubMed ID: 410877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of biologic activity from the purified alpha-chain of C5.
    Phan SH; Ward PA
    J Immunol; 1979 Dec; 123(6):2735-40. PubMed ID: 501087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biologically active complement (C5)-derived peptides and their relevance to disease.
    Perez HD
    Crit Rev Oncol Hematol; 1984; 1(3):199-225. PubMed ID: 6241542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cleavage of the fifth component of complement and generation of a functionally active C5b6-like complex by human leukocyte elastase.
    Vogt W
    Immunobiology; 2000 Jan; 201(3-4):470-7. PubMed ID: 10776801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limited proteolysis of C5b-6: functional stability of the degraded complex.
    Podack ER; Müller-Eberhard HJ
    J Immunol; 1980 Jan; 124(1):332-6. PubMed ID: 6444229
    [No Abstract]   [Full Text] [Related]  

  • 11. Digestion of the fifth component of complement by eosinophil lysosomal enzymes. Production of eosinophil specific chemotactic activity.
    Ogawa H; Kunkel SL; Fantone JC; Ward PA
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1981; 38(2):149-57. PubMed ID: 6119842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A simplified method for purification of human C5a from citrated plasma.
    Renfer L; Frank MM; Hammer CH; Harvath L; Lawley TJ; Yancey KB
    J Immunol Methods; 1986 Apr; 88(2):193-205. PubMed ID: 3514765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cleavage of the fifth component of human complement and release of a split product with C5a-like activity by crystalline silica through free radical generation and kallikrein activation.
    Governa M; Fenoglio I; Amati M; Valentino M; Bolognini L; Coloccini S; Volpe AR; Carmignani M; Fubini B
    Toxicol Appl Pharmacol; 2002 Mar; 179(3):129-36. PubMed ID: 11906242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the fifth and sixth components of the human complement system: C6-dependent cleavage of C5 in acid and the formation of a bimolecular lytic complex, C5b,6a.
    Hammer CH; Hänsch G; Gresham HD; Shin ML
    J Immunol; 1983 Aug; 131(2):892-8. PubMed ID: 6863934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial characterization of in vivo chemotactic activity: comparison to human C5a.
    Robinson LD; Wooten SK; Miller ME
    J Allergy Clin Immunol; 1977 May; 59(5):353-8. PubMed ID: 856901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of C5a by ASP, a serine protease released from Aeromonas sobria.
    Nitta H; Imamura T; Wada Y; Irie A; Kobayashi H; Okamoto K; Baba H
    J Immunol; 2008 Sep; 181(5):3602-8. PubMed ID: 18714034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement Activation in Arterial and Venous Thrombosis is Mediated by Plasmin.
    Foley JH; Walton BL; Aleman MM; O'Byrne AM; Lei V; Harrasser M; Foley KA; Wolberg AS; Conway EM
    EBioMedicine; 2016 Mar; 5():175-82. PubMed ID: 27077125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variability of biological effects of silicas: different degrees of activation of the fifth component of complement by amorphous silicas.
    Governa M; Amati M; Fenoglio I; Valentino M; Coloccini S; Bolognini L; Carlo Botta G; Emanuelli M; Pierella F; Volpe AR; Astolfi P; Carmignani M; Fubini B
    Toxicol Appl Pharmacol; 2005 Oct; 208(1):68-77. PubMed ID: 16164962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fifth component of guinea pig complement: purification and characterization.
    Kinoshita T; Hong K; Kondo K; Inoue K
    J Immunol; 1981 Jun; 126(6):2414-8. PubMed ID: 7229382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of C5a by phagocytic cells.
    Huber-Lang M; Younkin EM; Sarma JV; Riedemann N; McGuire SR; Lu KT; Kunkel R; Younger JG; Zetoune FS; Ward PA
    Am J Pathol; 2002 Nov; 161(5):1849-59. PubMed ID: 12414531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.